Table 1 Studies assessing the effect of environmental exposures on epigenetics in human PD cases.

From: Linking environmental risk factors with epigenetic mechanisms in Parkinson’s disease

Study

Sample size

Epigenetic measure

Tissue

Exposure

Main results

Chuang et al.35

Blood: Controls = 215 (PEG1 cohort); 2100 (WHI cohort), Saliva: Cases = 127 (PEG2 cohort), Controls = 129 (PEG2 cohort)

DNA methylation

Blood, saliva

Coffee consumption

• Hypomethylation of cg21566642 near ALPPL2 in blood linked to coffee consumption in controls at genome-wide significance

• Five CpGs significant at P < 5.0 × 10−6 (annotated to BSCL2, PODXL, CNTN4, GPR132 and ROBO3)

• No significant associations in saliva of PD cases or controls

Coupland et al.111

Leucocyte: Cases = 358, Controls = 1084; Brain cohort 1 (cerebellum): Controls = 69; Brain cohort 2 (cerebellum, anterior cingulate cortex, putamen): Cases = 28, Controls = 12

DNA methylation

Leucocytes, post-mortem brain

Vitamin E, PD drugs

MAPT hypermethylation associated with vitamin E levels in leucocyte controls

• Reduced MAPT methylation with levodopa use in leucocyte PD cases

Paul et al.115

SGPD: Cases = 959, Controls = 930; PEG: Cases = 569, Controls = 238

DNA methylation

Whole blood

Lead

• PD status strongly associated with DNA hypermethylation-derived predicted lead levels in the tibial bone, but not the patella bone

Go et al.113

Cases = 20 (blood, brain)

DNA methylation

Blood, post-mortem brain

Organochlorine pesticide

• Seven DMPs in PD post-mortem brain with 10+ years plantation work (top two hypermethylated and annotated to PTGDS and PEX19)

• 123 DMPs in blood (top two hypermethylated and annotated to WNT16 and ENTPD8)

Oliveira et al.112

Cases = 10, Controls = 9

Global H4 acetylation

Blood

Grape juice and exercise

• Global increase in H4 acetylation in blood of PD patients in response to exercise and grape juice treatment

• No differences between exercise alone and exercise plus grape juice

Henderson-Smith et al.45

Cases = 189, Controls = 191

DNA methylation

Blood

PD drugs

• 237 DMPs PD patients taking dopamine replacement therapies (between 0.63% reduction and 0.86% increase in DNA methylation per year).

Paul et al.117

Blood: Cases = 342, Controls = 238 (PEG1 cohort); Saliva: Cases = 128, Controls = 131 (PEG2 cohort)

DNA methylation

Blood, saliva

Organophosphate (OP) pesticides

• Seven DMPs associated with OP exposure in PD (annotated to ALOX12, HLA, HLA-L, HLA-DPA1, POLR1B and HDAC4).

Castillo et al.114

Cases = 97 (high-mining area = 45, low-mining area = 52), Controls = 111 (high-mining area = 52, low-mining area = 59)

DNA methylation

Whole blood

Heavy metal mining

• Lower DNAm levels in controls low mining towns

• No difference seen in PD cases

Searles Nielsen et al.116

Cases = 49, Controls = 103, Intermediate Controls (UPDRS3 ≥ 6 to <15) = 49

DNA methylation

Whole blood

Manganese

• Inverse association between NOS2 methylation and welding

• CpG site 8329 decreased in methylation with each year of welding exposure

Searles Nielsen et al.120

Cases = 292, Controls = 401

DNA methylation

PBMC

Smoking

• No association between LINE-1 methylation and PD in PBMCs

• Suggestive association between ever-smoking and PD; strongest in participants with low LINE-1 methylation

  1. PEG1 Parkinson’s Environment and Genes wave 1, PEG2 Parkinson’s Environment and Genes wave 2, WHI Women’s Health Initiative, SGPD System Genomics of PD, UPDRS3 Unified Parkinson’s Disease Rating Scale.